Identifying Arrhythmias in Adults With Congenital Heart Disease by 24-h Ambulatory Electrocardiography

Rodriguez, Fred H.; Moodie, Douglas S.; Neeland, Marc; Adams, Gerald J.; Snyder, Christopher S.

doi:10.1007/s00246-012-0183-1

Cited by 19 publications

(6 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Severity of congenital heart disease also correlates with development of arrhythmias, with moderate to severe forms having significantly higher risks; however, even those with mild forms still remain at some risk (Walsh and Cecchin, 2007 ). Much of our current understanding of arrhythmias and conduction system disease in patients with congenital heart disease have come from studies using 12-lead ECG and Holter monitor (Glatz et al, 2010 ; Rodriguez et al, 2012 ; Czosek et al, 2013 ). Data on longer duration recording are lacking.…”

Section: Arrhythmias and Conduction System Disorders Detection By Aecmentioning

confidence: 99%

Electrocardiographic patch devices and contemporary wireless cardiac monitoring

et al. 2015

View full text Add to dashboard Cite

Cardiac electrophysiologic derangements often coexist with disorders of the circulatory system. Capturing and diagnosing arrhythmias and conduction system disease may lead to a change in diagnosis, clinical management and patient outcomes. Standard 12-lead electrocardiogram (ECG), Holter monitors and event recorders have served as useful diagnostic tools over the last few decades. However, their shortcomings are only recently being addressed by emerging technologies. With advances in device miniaturization and wireless technologies, and changing consumer expectations, wearable “on-body” ECG patch devices have evolved to meet contemporary needs. These devices are unobtrusive and easy to use, leading to increased device wear time and diagnostic yield. While becoming the standard for detecting arrhythmias and conduction system disorders in the outpatient setting where continuous ECG monitoring in the short to medium term (days to weeks) is indicated, these cardiac devices and related digital mobile health technologies are reshaping the clinician-patient interface with important implications for future healthcare delivery.

show abstract

Section: Arrhythmias and Conduction System Disorders Detection By Aecmentioning

confidence: 99%

Electrocardiographic patch devices and contemporary wireless cardiac monitoring

et al. 2015

View full text Add to dashboard Cite

show abstract

“…A recent study revealed that 43% of these patients had arrhythmias on Holter monitoring, 90% of them being asymptomatic [65]. In another study with similar rate of asymptomatic rTOF patients (83%) most frequently recorded cumulative lifetime Holter findings were atrial (28%) and ventricular (44%) couplets/triplets, frequent premature ventricular contractions (25%) and non-sustained VT (10%) [66].…”

Section: Risk Assessment By Holter Monitoringmentioning

confidence: 91%

Late arrhythmia in patients with repaired tetralogy of Fallot: who is at risk?

Grigaliūnas

Gumbienė

Valevičienė

et al. 2015

Seminars in Cardiovascular Medicine

View full text Add to dashboard Cite

SummaryTetralogy of Fallot (TOF) is the most common cause of cyanotic congenital heart defect. Over the last century, the life expectancy of TOF patients has significantly improved. This, however, has brought new challenges both to patients and their health-care providers, the main of them being late arrhythmia. Ironically, late arrhythmia is predominantly generated due to the fibrotic scars caused by the life-saving surgical repair. Once the first two mainly arrhythmia-free decades after the repair pass, the risk of developing late arrhythmia and, therefore, SCD becomes substantial. Consequently, young adults with repaired Tetralogy of Fallot (rTOF) require careful outpatient monitoring.There have been many attempts to predict the risk of life-threatening arrhythmia in rTOF patients. This has led to the defining of various risk factors, ranging from the widely used QRS prolongation to novel predictors, derived from cardiac magnetic resonance (CMR) based anatomical findings (left ventricular dyssynchrony indexes, right ventricular output tract akinetic length, right ventricular mass-to-volume ratio). The latter predictors have recently established CMR as a tool of high significance in evaluation of rTOF patients.Although the role of Holter monitoring findings in rTOF patient-assessment remains unclear, it may be useful in those who are 25 years and older. Implantable cardioverter-defibrillator (ICD) implantation is the first-line treatment for secondary prevention of sudden cardiac death (SCD). rTOF patients suffer from the highest rate of inappropriate and the lowest rate of appropriate ICD shocks, when compared to other congenital heart diseases. As a consequence, ICD implantation for primary SCD prevention should be carefully weighed. Catheter-based ablation therapy leads to high rate of initial success when abolishing monomorphic ventricular tachycardia and intra-atrial reentrant tachycardia, however recurrence rates remain high. Seminars in Cardiovascular Medicine

show abstract

“…In one study, among the patients without arrhythmias on ECG, 26% had arrhythmias noted on Holter monitoring. Of the patients with multiple Holter monitoring performed, 34% had a new arrhythmia noted on repeat monitoring [16]. Certain ACHD patients are at higher risk for arrhythmias/sudden death, such as those with D-TGA and atrial baffle repairs, aortic stenosis, Fontan palliation or after repair of Tetralogy of Fallot.…”

Section: Non-invasive Testingmentioning

confidence: 99%

Atrial Arrhythmias in Adults with Repaired Congenital Heart Disease

Karpawich¹

2015

JCTCD

View full text Add to dashboard Cite

With advances in surgical and medical care over the past several decades, there has been a marked improvement in survival such that over 90% of children with Congenital Heart Disease (CHD) in developed countries today are expected to survive into adulthood. At present there are currently over 1 million adults with repaired congenital heart in the United States alone, over 100,000 in Canada, and 1.8 million in Europe. However, repaired congenital heart does not equate to a normal heart. In spite of excellent techniques, surgical repairs often left behind prosthetic materials and scars which often became the nidus for reentrant arrhythmias, especially atrial. Although sinus node dysfunction and resultant atrial flutter/ fibrillation become evident in the elderly, comparable atrial arrhythmias will occur among younger ACHD patients often in their second and third decades of life, and can range from asymptomatic to hemodynamically significant and potentially lethal. In the long term, arrhythmias are a leading cause of morbidity and mortality in adults with repaired CHD. This review discusses current approaches to atrial arrhythmia identification and management among ACHD patients.

show abstract

Identifying Arrhythmias in Adults With Congenital Heart Disease by 24-h Ambulatory Electrocardiography

Cited by 19 publications

References 17 publications

Electrocardiographic patch devices and contemporary wireless cardiac monitoring

Electrocardiographic patch devices and contemporary wireless cardiac monitoring

Late arrhythmia in patients with repaired tetralogy of Fallot: who is at risk?

Atrial Arrhythmias in Adults with Repaired Congenital Heart Disease

Contact Info

Product

Resources

About